Atidarsagene autotemcel, sold under the brand name name Libmeldy among Other individuals, is actually a gene therapy treatment method for metachromatic leukodystrophy formulated by Orchard Therapeutics. To make Libmeldy, the CD34+ cells (cells that could make white blood cells) are extracted with